Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets. Clare and Stefan discuss:  - Preparing for access to Switzerland – a European market outside the EU  - Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)  - Launching in Germany – is this still one of the most attractive European markets?  - The Financial Stabilisation Act in Germany – what this means for drug pricing Learn more at: https://mtechaccess.co.uk/market-acce... This episode was first broadcast as a live webinar in July 2023.  Subscribe to our newsletter to hear more news, insights and events from Mtech Access.